Literature DB >> 6206720

Precipitating antimitochondrial antibodies in Japanese patients with primary biliary cirrhosis.

K Miyachi, S Watanabe, M Yamashiki, T Hiwatashi, F Ichida.   

Abstract

The prevalence of three precipitating antibodies to mitochondria A (M-A), mitochondria B (M-B), and mitochondria C (M-C), reacting with the antigens in the mitochondrial fraction of sonicated rat liver was studied in Japanese patients with primary biliary cirrhosis and other liver diseases. Antibodies to M-A and M-B were found in 12 of 22 (54%) and 11 of 22 (50%) patients, respectively. Antibodies to M-C were found in only one of 22 (4%) patients. The titers of antibodies to M-A and M-B correlated with the titers of mitochondrial immunofluorescence staining on unfixed mouse kidney section (r = 0.71 and 0.81, respectively). These antibodies were not present in liver cirrhosis (20 patients), chronic active hepatitis (20), acute viral hepatitis (10), and hepatoma (10). However, the titers of these antibodies did not correlate with amount of immunoglobulin, immune complexes, and the severity of disease. This work confirms that the antibodies to M-A and M-B are also marker antibodies for Japanese patients with primary biliary cirrhosis.

Entities:  

Mesh:

Substances:

Year:  1984        PMID: 6206720

Source DB:  PubMed          Journal:  Am J Gastroenterol        ISSN: 0002-9270            Impact factor:   10.864


  2 in total

Review 1.  A case of combined primary biliary cirrhosis, ulcerative colitis and chronic myelocytic leukemia.

Authors:  K Akahoshi; Y Miyata; M Hashimoto; S Koga; Y Chijiiwa; T Misawa; E Suematsu; J Nishimura; H Nawata
Journal:  Gastroenterol Jpn       Date:  1992-04

2.  Immunoreactivity of antimitochondrial autoantibodies in Japanese patients with primary biliary cirrhosis.

Authors:  K Omagari; M J Rowley; J A Jois; S J Feeney; K Komatsu; T Maeda; S Onishi; K Yamazaki; K Suzuki; C Galperin; I R Mackay
Journal:  J Gastroenterol       Date:  1996-02       Impact factor: 7.527

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.